XML 34 R26.htm IDEA: XBRL DOCUMENT
v3.24.2

Stockholders' Equity (Tables) | 6 Months Ended
--- | ---
May 31, 2024
Fair Value of Options Granted | Variables used to determine the fair value of the options granted for the three and six months ended May 31, 2024 and 2023, respectively, are as follows:
|  | Three months ended |  | Six months ended
|  | May 31, |  | May 31, |  | May 31, |  | May 31,
|  | 2024 |  | 2023 |  | 2024 |  | 2023
Weighted average values: |  |  |  |  |  |  |  |
Expected dividends |  | 0% |  | 0% |  | 0% |  | 0%
Expected volatility |  | — |  | — |  | 60.52% |  | 55.00%
Risk free interest rate |  | — |  | — |  | 3.87% |  | 3.87%
Expected life |  | — |  | — |  | 5 years |  | 5 years
Stock Option Activity | Stock option activity for options with only service-based vesting conditions for the six months ended May 31, 2024, was as follows:
|  |  |  |  | Weighted |  |  | Weighted Average Remaining |  |  |  |
|  |  |  |  | Average |  |  | Contractual |  |  | Aggregate |
|  | Options |  |  | Exercise Price |  |  | Term (Years) |  |  | Intrinsic Value |
Outstanding at November 30, 2023 |  |  | 404,278 |  |  | $ | 7.36 |  |  | 4.49 |  |  | $ | 135,330 |
Granted |  |  | 103,000 |  |  |  | 6.31 |  |  |  |  |  |  | 196,770 |
Exercised |  |  | — |  |  |  | — |  |  |  |  |  |  | — |
Expired/forfeited |  |  | (1,500 | ) |  |  | 7.04 |  |  |  |  |  |  | 1,770 |
Outstanding at May 31, 2024 |  |  | 505,778 |  |  | $ | 7.14 |  |  |  | 4.11 |  |  | $ | 884,103 |
Exercisable at May 31, 2024 |  |  | 375,718 |  |  | $ | 7.50 |  |  |  | 4.06 |  |  | $ | 594,908 |
Significant Option Groups Exercisable Option and its Price and Contractual Life | Significant option groups outstanding and exercisable at May 31, 2024 and related price and contractual life information are as follows:
|  | Outstanding |  |  | Exercisable |
|  |  |  |  | Weighted Average |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Remaining |  |  | Weighted |  |  |  |  |  | Weighted |
Range of Exercise Prices |  | Outstanding |  |  | Contractual Life (Years) |  |  | Average Exercise Price |  |  | Outstanding |  |  | Average Exercise Price |
$3.01 to $4.00 |  |  | 25,000 |  |  |  | 1.69 |  |  | $ | 3.13 |  |  |  | 25,000 |  |  | $ | 3.13 |
$4.01 to $5.00 |  |  | 123,600 |  |  |  | 4.09 |  |  | $ | 4.70 |  |  |  | 78,665 |  |  | $ | 4.68 |
$5.01 to $6.00 |  |  | 28,000 |  |  |  | 4.56 |  |  | $ | 5.88 |  |  |  | 9,332 |  |  | $ | 5.88 |
$6.01 to $7.00 |  |  | 89,433 |  |  |  | 4.91 |  |  | $ | 6.48 |  |  |  | 39,430 |  |  | $ | 6.48 |
$7.01 to $8.00 |  |  | 149,645 |  |  |  | 4.86 |  |  | $ | 7.54 |  |  |  | 142,443 |  |  | $ | 7.52 |
$9.01 to $10.00 |  |  | 29,000 |  |  |  | 3.76 |  |  | $ | 9.37 |  |  |  | 21,583 |  |  | $ | 9.37 |
$12.01 to $13.00 |  |  | 16,653 |  |  |  | 6.23 |  |  | $ | 12.54 |  |  |  | 14,818 |  |  | $ | 12.55 |
$13.01 to $14.00 |  |  | 44,447 |  |  |  | 0.56 |  |  | $ | 13.50 |  |  |  | 44,447 |  |  | $ | 13.50 |
|  |  | 505,778 |  |  |  | 4.11 |  |  | $ | 7.14 |  |  |  | 375,718 |  |  | $ | 7.50 |
Summary of Non-Vested Options | A summary of the status of the Company’s non-vested options as of May 31, 2024, and changes during the six months ended May 31, 2024, is presented below:
|  |  |  |  | Weighted Average |
|  |  |  |  | Grant-Date |
|  | Options |  |  | Fair Value |
Non-vested at November 30, 2023 |  |  | 114,193 |  |  | $ | 3.10 |
Granted |  |  | 103,000 |  |  |  | 3.13 |
Vested |  |  | (87,133 | ) |  |  | 3.30 |
Forfeited |  |  | — |  |  |  | — |
Non-vested at May 31, 2024 |  |  | 130,060 |  |  | $ | 2.99 |

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration